Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Female Hypoactive Sexual Desire Disorder Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Female Hypoactive Sexual Desire Disorder Therapeuticsmarket, defines the market attractiveness level of Female Hypoactive Sexual Desire Disorder Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Female Hypoactive Sexual Desire Disorder Therapeutics industry, describes the types of Female Hypoactive Sexual Desire Disorder Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Female Hypoactive Sexual Desire Disorder Therapeutics market and the development prospects and opportunities of Female Hypoactive Sexual Desire Disorder Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Female Hypoactive Sexual Desire Disorder Therapeutics market in Chapter 13.
By Player:
Emotional Brain BV
Strategic Science & Technologies LLC
GlaxoSmithKline Plc
Pivot Pharmaceuticals Inc
Palatin Technologies Inc
By Type:
BP-101
Bremelanotide
Gepirone Hydrochloride ER
PVT-011
Others
By End-User:
Out-Patient
In-Patient
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Female Hypoactive Sexual Desire Disorder Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Female Hypoactive Sexual Desire Disorder Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Female Hypoactive Sexual Desire Disorder Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Female Hypoactive Sexual Desire Disorder Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Female Hypoactive Sexual Desire Disorder Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Consumption (2017-2022)
-
7.2 United States Female Hypoactive Sexual Desire Disorder Therapeutics Consumption (2017-2022)
-
7.3 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Consumption (2017-2022)
-
7.4 China Female Hypoactive Sexual Desire Disorder Therapeutics Consumption (2017-2022)
-
7.5 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Consumption (2017-2022)
-
7.6 India Female Hypoactive Sexual Desire Disorder Therapeutics Consumption (2017-2022)
-
7.7 South Korea Female Hypoactive Sexual Desire Disorder Therapeutics Consumption (2017-2022)
8 Region and Country-wise Female Hypoactive Sexual Desire Disorder Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Female Hypoactive Sexual Desire Disorder Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Female Hypoactive Sexual Desire Disorder Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Female Hypoactive Sexual Desire Disorder Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Female Hypoactive Sexual Desire Disorder Therapeutics Consumption Forecast (2022-2028)
9 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global BP-101 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Bremelanotide Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Gepirone Hydrochloride ER Consumption and Growth Rate (2017-2022)
-
9.1.4 Global PVT-011 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Out-Patient Consumption and Growth Rate (2017-2022)
-
9.2.2 Global In-Patient Consumption and Growth Rate (2017-2022)
10 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global BP-101 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Bremelanotide Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Gepirone Hydrochloride ER Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global PVT-011 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Out-Patient Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global In-Patient Consumption Forecast and Growth Rate (2022-2028)
11 Global Female Hypoactive Sexual Desire Disorder Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Female Hypoactive Sexual Desire Disorder Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Competitive Analysis
-
14.1 Emotional Brain BV
-
14.1.1 Emotional Brain BV Company Details
-
14.1.2 Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Product and Service
-
14.2 Strategic Science & Technologies LLC
-
14.2.1 Strategic Science & Technologies LLC Company Details
-
14.2.2 Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Product and Service
-
14.3 GlaxoSmithKline Plc
-
14.3.1 GlaxoSmithKline Plc Company Details
-
14.3.2 GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Product and Service
-
14.4 Pivot Pharmaceuticals Inc
-
14.4.1 Pivot Pharmaceuticals Inc Company Details
-
14.4.2 Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Product and Service
-
14.5 Palatin Technologies Inc
-
14.5.1 Palatin Technologies Inc Company Details
-
14.5.2 Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Female Hypoactive Sexual Desire Disorder Therapeutics
-
Figure Female Hypoactive Sexual Desire Disorder Therapeutics Picture
-
Table Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Female Hypoactive Sexual Desire Disorder Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Female Hypoactive Sexual Desire Disorder Therapeutics Consumption by Country (2017-2022)
-
Figure United States Female Hypoactive Sexual Desire Disorder Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Female Hypoactive Sexual Desire Disorder Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Female Hypoactive Sexual Desire Disorder Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Female Hypoactive Sexual Desire Disorder Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Female Hypoactive Sexual Desire Disorder Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Female Hypoactive Sexual Desire Disorder Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Female Hypoactive Sexual Desire Disorder Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Female Hypoactive Sexual Desire Disorder Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Female Hypoactive Sexual Desire Disorder Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Female Hypoactive Sexual Desire Disorder Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Female Hypoactive Sexual Desire Disorder Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Female Hypoactive Sexual Desire Disorder Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Female Hypoactive Sexual Desire Disorder Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BP-101 Consumption and Growth Rate (2017-2022)
-
Figure Global Bremelanotide Consumption and Growth Rate (2017-2022)
-
Figure Global Gepirone Hydrochloride ER Consumption and Growth Rate (2017-2022)
-
Figure Global PVT-011 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Out-Patient Consumption and Growth Rate (2017-2022)
-
Figure Global In-Patient Consumption and Growth Rate (2017-2022)
-
Figure Global BP-101 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bremelanotide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gepirone Hydrochloride ER Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PVT-011 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Out-Patient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global In-Patient Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Female Hypoactive Sexual Desire Disorder Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Female Hypoactive Sexual Desire Disorder Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Emotional Brain BV (Foundation Year, Company Profile and etc.)
-
Table Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Product and Service
-
Table Strategic Science & Technologies LLC (Foundation Year, Company Profile and etc.)
-
Table Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Product and Service
-
Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Product and Service
-
Table Pivot Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Product and Service
-
Table Palatin Technologies Inc (Foundation Year, Company Profile and etc.)
-
Table Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Product and Service
-
